Literature DB >> 32833639

Deep Spatio-Temporal Representation and Ensemble Classification for Attention Deficit/Hyperactivity Disorder.

Shuaiqi Liu, Ling Zhao, Xu Wang, Qi Xin, Jie Zhao, David S Guttery, Yu-Dong Zhang.   

Abstract

Attention deficit/Hyperactivity disorder (ADHD) is a complex, universal and heterogeneous neurodevelopmental disease. The traditional diagnosis of ADHD relies on the long-term analysis of complex information such as clinical data (electroencephalogram, etc.), patients' behavior and psychological tests by professional doctors. In recent years, functional magnetic resonance imaging (fMRI) has been developing rapidly and is widely employed in the study of brain cognition due to its non-invasive and non-radiation characteristics. We propose an algorithm based on convolutional denoising autoencoder (CDAE) and adaptive boosting decision trees (AdaDT) to improve the results of ADHD classification. Firstly, combining the advantages of convolutional neural networks (CNNs) and the denoising autoencoder (DAE), we developed a convolutional denoising autoencoder to extract the spatial features of fMRI data and obtain spatial features sorted by time. Then, AdaDT was exploited to classify the features extracted by CDAE. Finally, we validate the algorithm on the ADHD-200 test dataset. The experimental results show that our method offers improved classification compared with state-of-the-art methods in terms of the average accuracy of each individual site and all sites, meanwhile, our algorithm can maintain a certain balance between specificity and sensitivity.

Mesh:

Year:  2021        PMID: 32833639     DOI: 10.1109/TNSRE.2020.3019063

Source DB:  PubMed          Journal:  IEEE Trans Neural Syst Rehabil Eng        ISSN: 1534-4320            Impact factor:   3.802


  1 in total

1.  Continuous Sign Language Recognition through a Context-Aware Generative Adversarial Network.

Authors:  Ilias Papastratis; Kosmas Dimitropoulos; Petros Daras
Journal:  Sensors (Basel)       Date:  2021-04-01       Impact factor: 3.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.